PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Polyether Polyketides”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8Linked to original sources

The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth.

E7389, which is in phase I and II clinical trials, is a synthetic macrocyclic ketone analogue of the marine sponge natural product halichondrin B. Whereas its mechanism of action has not been fully elucidated, its main target seems to be tubulin and/or the microtubules responsible for the construction and proper function of the mitotic spindle. Like most microtubule-targeted antitumor drugs, it inhibits tumor cell proliferation in association with G(2)-M arrest. It binds to tubulin and inhibits microtubule polymerization. We examined the mechanism of action of E7389 with purified microtubules and in living cells and found that, unlike antimitotic drugs including vinblastine and paclitaxel that suppress both the shortening and growth phases of microtubule dynamic instability, E7389 seems to work by an end-poisoning mechanism that results predominantly in inhibition of microtubule growth, but not shortening, in association with sequestration of tubulin into aggregates. In living MCF7 cells at the concentration that half-maximally blocked cell proliferation and mitosis (1 nmol/L), E7389 did not affect the shortening events of microtubule dynamic instability nor the catastrophe or rescue frequencies, but it significantly suppressed the rate and extent of microtubule growth. Vinblastine, but not E7389, inhibited the dilution-induced microtubule disassembly rate. The results suggest that, at its lowest effective concentrations, E7389 may suppress mitosis by directly binding to microtubule ends as unliganded E7389 or by competition of E7389-induced tubulin aggregates with unliganded soluble tubulin for addition to growing microtubule ends. The result is formation of abnormal mitotic spindles that cannot pass the metaphase/anaphase checkpoint.

Animals↗

Prompt recovery of damaged adrenal medullae induced by salinomycin.

The morphologic changes in the adrenal medullae of rats treated with an ionophore antibiotic, salinomycin, are described. Male rats of approximately 7 wk of age were treated orally with a single dose of salinomycin at 80 mg/kg body weight. Following this treatment, the adrenal glands were examined, using immunohistochemistry, for neurofilament, laminin, fibronectin, and S-100 protein; the glands were also examined using transmission electron microscopy. One hour after the treatment, a karyopyknosis was observed in the clusters of affected chromaffin cells in which the neurofilament, laminin, and fibronectin were present. The lesions became progressively conspicuous between hours 5 and 10. Ultimately, the outcome was cell lysis. Five hours after salinomycin treatment, unaffected chromaffin cells strongly stained to tyrosine hydroxylase. At 10 hr, new chromaffin cells, which were irregular in shape with electron-dense cytoplasm (dark cell), that were strongly stained for tyrosine hydroxylase appeared at the basement membrane site of the necrotic clusters, and these cells contained very few immature catecholamine granules of less than 80 nm. At 17 hr, the catecholamine granules increased in number and size to about 200 nm. The newly formed chromaffin cells grew within the clusters to fill in the medulla by 24 hr, and cytoplasmic granules progressively increased in number and size. The interstitial tissue was seen to be edematous at 5 hr. New capillaries were found in the adrenal medullae of both control and salinomycin-treated rats. The protruding chromaffin cells (protruding cells), which we previously described in normal rats, were also observed in salinomycin-treated rats, which suggests that holocrine secretion is performed in the adrenal medullae. The results indicated that the rat adrenal medullae have the ability to make a rapid recovery after an insult by salinomycin.

Adrenal Medulla↗

The impact of a successful anti-myxosporean treatment on the phagocyte functions of juvenile and adult Sparus aurata L.

The aim of the present study was to investigate the impact of a successful anti-myxosporean medication on the innate immune system of fish intensively cultured in the Mediterranean basin. For this purpose, juvenile and adult gilthead seabream (S. aurata L.) naturally infected with Polysporoplasma sparis in the kidney were used in a small-scale field trial. The infected fish were treated orally with the combination of salinomycin and amprolium, two drugs well known for their anti-coccidial effect in other animals. Drug efficacy and safety was evaluated in terms of changes observed in histopathology, mortality and P. sparis intensity and prevalence rate. Phagocytic functions of head-kidney leucocytes were also investigated at the end as well as one month post the medication. Salinomycin with amprolium exhibited a significant reduction in intensity and prevalence rate in both juvenile and adult fish, and no histopathological evidence for toxic side effects was observed. In addition, the successful treatment was closely correlated with a complete restoration of the diminished phagocytic ability and capacity as well as NO, and lysozyme secretion in a time dependent manner. This data suggests that salilomycin with amprolium can be an alternative treatment for myxosporean infections in tropical fish, possibly exhibiting their action through the enhancement of host innate functions.

Amprolium↗

[Stereoselective synthesis of macrolide and polyether antibiotics].

In order to establish a common methodology for the highly stereoselective and efficient synthesis of macrolide and polyether antibiotics, two macrolide aglycons, 12-membered ring methynolide and 16-membered ring tylonolide, were first synthesized mainly from D-glucose, with the aid of 4-methoxybenzyl (MPM) type protecting groups and construction of three consecutive chiral centers, via the syntheses of respective fragments followed by their coupling (Yamaguchi's esterification) and cyclization (Wittig-Horner reaction). This method was extended to the synthesis of 14-membered ring pikronolide and, together with conformational analysis and control of macrolide rings, some typical 16-membered ring aglycons such as carbonolides, leuconolides, maridonolides, etc. Erythronolide A was also synthesized via an extremely efficient macrolactonization by virtue of conformational control and super activation of a seco-acid. For the synthesis of polyether antibiotics a new synthetic method of substituted tetrahydrofuran and -pyran rings was first established via a cyclization of styryl derivatives by acid catalyzed and/or chelation controlled reactions under kinetic and/or thermodynamic conditions. Highly complex polyether salinomycin was synthesized via coupling of three fragments prepared from D-glucose, D-mannitol, and ethyl L-lactate essentially by the same method developed in the synthesis of macrolides. In this synthesis the MPM type protecting groups acted a crucial role. The synthesis of isolasalocid A was completed via isolasalocid ketone, in which two tetrahydrofuran rings were constructed by the above acid catalyzed and chelation controlled cyclizations. Similarly lasalocid A was synthesized from D-glucose via lasalocid ketone.

Anti-Bacterial Agents↗

Salinomycin-induced polyneuropathy in cats: morphologic and epidemiologic data.

In April 1996, an outbreak of toxic polyneuropathy in cats occurred in the Netherlands. All cats had been fed one of two brands of dry cat food from one manufacturer. Chemical analyses of these foods, stomach contents, and liver and kidney of affected cats revealed contamination with the ionophor salinomycin. Epidemiologic and clinical data were collected from 823 cats, or about 1% of the cats at risk. In 21 affected cats, postmortem examination was performed. The affected cats had acute onset of lameness and paralysis of the hindlimbs followed by the forelimbs. Clinical and pathologic examination indicated a distal polyneuropathy involving both the sensory and motor nerves.

Animal Feed↗

Coccidiosis control with toltrazuril in conjunction with anticoccidial medicated or nonmedicated feed.

A 42-day broiler floor pen study was conducted comparing the anticoccidial efficacy of toltrazuril (Baycox) as a stand alone treatment and as an additional treatment to in-feed anticoccidial programs. Toltrazuril was administered on days 18 and 19 in the drinking water at 7 mg/kg of body weight. The treatments were 125 ppm nicarbazin (days 0-14) to 66 ppm salinomycin (SAL) (days 15-35) with and without toltrazuril, SAL (days 0-35) with and without toltrazuril, nonmedicated (NM) to SAL with toltrazuril, and NM with and without toltrazuril. The controls were NM noninfected and infected. The treatments were replicated in five blocks of eight pens each in a randomized complete block design. All withdrawal feed was nonmedicated. On day 14, birds, except noninfected, were exposed to coccidial oocysts (Eimeria acervulina, Eimeria maxima, and Eimeria tenella) seeded litter. On days 21, 28, 35, and 42, birds and feed were weighed, four birds per pen were coccidial lesion scored, and litter oocyst counts were performed. The coccidial infection in the NM infected treatment caused a significant (P < 0.05) coccidiosis infection. Coccidiosis was moderately controlled in the anticoccidial treatment birds without toltrazuril. Performance in the NM with toltrazuril was equal to or better (P < 0.05) than the anticoccidial programs without toltrazuril. Toltrazuril was equal to the noninfected birds in performance. Toltrazuril most completely eliminated all coccidial lesions and dramatically reduced oocyst shedding. The performance data, lesion scores, and oocyst counts showed that a 2-day treatment with toltrazuril successfully controlled the coccidiosis with no relapse of infection. Toltrazuril can thus be used for supplemental control with in-feed anticoccidials or as a primary anticoccidial with nonmedicated feed.

Animal Feed↗

Beneficial effect of beta-mannanase feed enzyme on performance of chicks challenged with Eimerla sp. and Clostridium perfringens.

Two experiments were conducted to determine the effect of a beta-mannanase feed enzyme on the performance of broiler chicks subject to a necrotic enteritis disease challenge model involving oral inoculation of Eimeria sp. and Clostridium pefringens. Beta-mannanase is known to improve productive performance when added to poultry and swine diets. In both experiments, disease challenge in the absence of feed additives demonstrated significant reductions in performance as measured by weight gain, feed conversion, and the incidence of coccidial lesion scores. Significant mortality was also observed in challenged groups in Experiment 1. The disease challenge model was therefore judged as highly effective. Additions of a commonly used antibiotic, bacitracin methylene disalicilate (BMD), and coccidiostat, salinomycin, were highly effective in partially counteracting negative effects of the disease challenge. In both experiments, addition of beta-mannanase significantly improved performance and reduced lesion scores in disease-challenged groups. The degree of improvement was somewhat less than that afforded by a combination of BMD and salinomycin in Experiment 1 but was not different from that afforded by BMD alone in Experiment 2. We conclude that the beta-mannanase enzyme can play a role in circumstances where the use of antibiotics is not desired.

Animal Feed↗

Inhibition of resistance plasmid transfer in Escherichia coli by ionophores, chlortetracycline, bacitracin, and ionophore/antimicrobial combinations.

Medicinal feed additives bacitracin, chlortetracycline (CTC), laidlomycin, lasalocid, and salinomycin inhibited the transfer of multiresistance-conferring plasmid pBR325 (Tet(r) Amp(r) Cp(r), 6.0 kb) into selected gram-negative strains with the use of an in vitro model. High concentrations of ampicillin-sensitive competence-pretreated Escherichia coli HB 101 cells were exposed to 10% (v/v) of 1:10 dimethyl sulfoxide/agent : water containing test mixtures for 0.5 hr prior to plasmid addition and transforming conditions. Transformation was inhibited for all antimicrobials and showed a positive association wich higher concentration. Additional testing of ionophore compounds separately and in combination with bacitracin, chlortetracycline, lincomycin, roxarsone, tylosin, and virginiamycin at representative feed concentrations demonstrated 80.6% to >99.9% inhibition (P < 0.001) of resistance transfer. Bacitracin alone inhibited transformation within the range of 50-500 ppm. No increase in resistance transfer was observed when poultry-derived and reference gram-negative isolates having low or no transformation efficiency were additionally tested. The results suggest that these compounds, at relevant concentrations used in animal feed, may interfere with cell envelope-associated DNA uptake channels or other transformation competence mechanisms. Through these mechanisms, ionophores and cell membrane-interactive feed agents such as CTC and bacitracin may act to inhibit resistance transfer mechanisms within poultry and livestock.

Bacitracin↗

Increased level of Eimeria sensitivity to diclazuril after using a live coccidial vaccine.

Anticoccidial vaccine and an anticoccidial drug rotation program were compared to determine which program was more effective in producing coccidia populations sensitive of 1 ppm diclazuril. The study used an anticoccidial drug-sensitivity battery test (AST) to determine the baseline level of diclazuril sensitivity to field isolates of Eimeria spp. from seven broiler complexes that had used diclazuril. Based on percentage reduction in weight gain and lesion scores, 25% or fewer of the isolates were effectively controlled by diclazuril. Following the baseline sampling, four of the complexes switched to a nondiclazuril in-feed anticoccidial drug program and three of the complexes switched to a vaccination program for two broiler grow-out cycles as the sole coccidiosis-control program. This study demonstrated that the vaccine used (Coccivac-B) contained anticoccidial drug-sensitive strains. Eimeria isolates were subsequently collected from the identical houses and diclazuril AST results were compared with the baseline AST results. Following the two grow-out cycles, sensitivity of the isolates to diclazuril from the four complexes that continued to use in-feed anticoccidial drugs remained essentially unchanged. The isolates from the three complexes that switched to the vaccination program demonstrated a marked increase in diclazuril sensitivity, with 60%-100% of the isolates from each complex effectively controlled by diclazuril. Vaccination with the anticoccidial drug-sensitive strains produced a measurable increase in the level of sensitivity to diclazuril.

Animals↗

Effect of salinomycin on giardiasis and coccidiosis in growing lambs.

An experiment was undertaken to determine the effect of salinomycin on Giardia in vitro and on Giardia and coccidia in growing lambs. Concentrations of salinomycin above (3.9 micrograms/mL) reduced the adherence (index of viability) of Giardia S2 trophozoites by more than 50%. This strain did not develop resistance after repeated exposure to sublethal concentrations of salinomycin. Five of 40 lambs escaped natural infection by Giardia, and these were inoculated with > or = 500,000 cysts. Giardiasis (presence of cysts in feces) was confirmed in all lambs before commencement of the experiment. Coccidiosis (presence of oocysts) developed by natural exposure. Lambs were assigned randomly to diets containing 0, 4, 10, or 16 ppm of salinomycin. Giardia cyst and coccidia oocyst excretions were determined on 6 d during the first week and weekly thereafter. Giardia cysts were detected at each sampling date in all treatments (highest release, 2.3 x 10(6) cysts/g feces). The number of Giardia cysts shed in feces was not affected (P > .05) by salinomycin but did decline (P < .05) with time. Average infection rates remained above 50% until d 41 of the experiment and declined linearly (P < .05) with salinomycin concentration and time. The number of coccidia oocysts in feces was low (highest release, 6.8 x 10(4) oocysts/g feces), but shedding occurred in 38 of the 40 lambs. Treatment with salinomycin had a cubic effect (P < .05) on coccidia oocyst excretion, and no oocysts were detected beyond d 28. Treatment effect on average daily gain (P < .002), dry matter intake (P < .02), and final live weight (P < .07) was cubic, whereas carcass weight (P < .003) and dressing percentage (P < .08) were linearly affected by salinomycin concentration. Although a beneficial effect of 10 ppm salinomycin on lamb performance was apparent, the development of natural resistance makes it difficult to attribute this response to the control of coccidiosis or giardiasis.

Administration, Oral↗

An unaddressed issue of agricultural terrorism: a case study on feed security.

In the late winter of 2003, a number of livestock animals in the Midwest were poisoned due the accidental contamination of a popular commercial feed with a lethal additive. Although all the evidence indicates this incident had no malicious or terrorist intent, it is informative as a case study highlighting potential security implications with respect to a terrorist event directed at U.S. agriculture.

Agriculture↗

Effect of salinomycin level on nutrient digestibility and ruminal characteristics of sheep and feedlot performance of cattle.

A sheep digestion trial and two feedlot trials with cattle were conducted to study effects of an ionophore, salinomycin, on nutrient digestibility, ruminal metabolism and cattle performance. In trial 1, addition of salinomycin at 5.5, 11 or 22 ppm to 60% concentrate diets fed to ruminal-cannulated rams had no effect (P greater than .05) on apparent digestibility of dry matter (DM), organic matter (OM), neutral detergent fiber (NDF), acid detergent fiber (ADF) or starch in comparison with control diets. Apparent nitrogen (N) digestibility was increased (P less than .05) in animals fed salinomycin. Salinomycin did not affect total volatile fatty acid (VFA) concentrations in the rumen, but resulted in a linear (P less than .05) increase in molar proportion of propionate and a linear (P less than .05) decrease in molar proportions of acetate and butyrate and in acetate:propionate ratios. Shifts in VFA proportions were fully expressed within 4 d after salinomycin was added to the diet. In trial 2, salinomycin was added at 5.5, 11, 22 or 33 ppm to 85% concentrate diets fed to finishing steers. Salinomycin level had a quadratic effect (P less than .05) on daily weight gain and resulted in a quadratic (P less than .05) decrease in feed intake with a resultant average improvement of 10.3% in feed efficiency. Salinomycin (5.5, 11, 16.5 or 22 ppm) and monensin (22 ppm) were added to 90% concentrate diets in trial 3 and produced increased rates of gain without affecting feed intake.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

The efficacy of salinomycin as a growth promotant for swine from 9 to 97 kg.

Six trials involving 586 pigs initially averaging 9 kg were conducted at three locations (two trials/location) to evaluate the effects of the dietary addition of 0, 27.5, 55, 82.5 and 110 ppm of a monocarboxylic polyether antibiotic, salinomycin, on feed intake, growth rate and feed efficiency of swine fed corn-soybean meal-based diets. Over the total trial (9 to 97 kg), quadratic improvements in gain (P less than .01) and feed:gain (P less than .04) occurred with increasing level of salinomycin, but feed intake was not affected (P greater than .25). Mean improvements for all drug levels over control values for the total trial were 4.3% for daily gain (P less than .01) and 3.4% for feed:gain (P less than .01). For the total trial, rate and efficiency of gain were optimized in pigs fed the 82.5-ppm level of salinomycin with an improvement of 5.2% in daily gain and 4.8% in feed:gain over pigs fed the control diet. The absence of any significant trial X treatment interaction suggests that the nature of the response was not dependent on differences in environment, management or other factors that existed among trial locations.

Animal Feed↗

Effect of salinomycin supplementation on characteristics of digestion and feedlot performance of cattle.

One hundred fifty large-frame British-cross calves, 75 heifers and 75 steers averaging 220 kg, were used in a 187-d growing-finishing trial to study the influence of dietary salinomycin levels of 0, 5.5, 11, 16.5 and 22 mg/kg on rate and efficiency of gain. The basal diet to which the ionophore was added was composed largely to steam processed grains, and contained 3% supplemental fat. Performance responses to salinomycin supplementation were similar for steers and heifers. Rate of gain was not influenced (P greater than .20); however, feed conversion was improved by an average of 5% at the 11- to 22-mg/kg levels of salinomycin supplementation (P less than .05). Although not necessarily mutually exclusive, this improvement in feed conversion could be accounted for as either a 5% increase in the net energy value of the diet (P less than .05) or a 10% reduction in maintenance requirement (P less than .10). Four steer calves (234 kg) with cannulae in the rumen and proximal duodenum were used in a 4 X 4 Latin-square design trial to determine the influence of salinomycin supplementation on characteristics of digestion. Four levels of supplementation (0, 55, 11 and 16.5 mg/kg) were evaluated using the same basal diet as in the performance trial. Total tract digestion of organic matter, acid detergent fiber, starch and protein was not significantly altered by salinomycin supplementation. However, ruminal digestion of organic matter was reduced 6.2% (P less than .05). Neither ruminal degradation of feed protein nor net microbial synthesis was significantly altered.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Influence of forage level on response of feedlot steers to salinomycin supplementation.

Two trials were conducted to evaluate the influence of forage level on the response of feedlot cattle to salinomycin. Diets containing 10, 15 and 20% forage were compared with 0 or 11 mg/kg salinomycin. In trial 1, treatment effects on feedlot performance were evaluated using 108 crossbred steers (295 kg) in a crossover design experiment. There were no salinomycin X forage level interactions (P greater than .20). Weight gain response to salinomycin supplementation averaged 5.4, 5.3 and 6.9%, respectively, for diets containing 10, 15 and 20% forage. Corresponding values for feed conversion response to salinomycin supplementation were 5.1, 3.9 and 5.9%. Averaged across forage level, salinomycin supplementation improved rate of weight gain and feed conversion by 5.9 and 5.2%, respectively (P less than .01). In trial 2, treatment effects on characteristics of ruminal and total tract digestion were evaluated in a 6 X 6 Latin-square design trial involving six crossbred steers (191 kg) with cannulae in the rumen and proximal duodenum. There were no interactions between salinomycin supplementation and forage level on characteristics of ruminal digestion (P greater than .20). Salinomycin supplementation did not influence synthesis of microbial N, ruminal digestion of organic matter, acid detergent fiber and starch, or molar proportions of acetate, propionate and butyrate (P greater than .20). Salinomycin supplementation increased passage of non-ammonia N to the small intestine (5.4%, P less than .10) and increased ruminal escape of feed N (24%, P less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Effects of salinomycin on sow weight change during lactation and on sow reproductive performance.

Forty-five gravid cross-bred sows (mean parity 3.3 +/- .3) were randomly allotted to two dietary treatments: corn-soybean mean (CS) or CS plus 60 mg salinomycin per kilogram of diet (CSS). Sows were fed their respective diets through two successive parities with dietary treatment initiated at 100 d postcoitum and continued until weaning of the second successive litter. Therefore, sows fed CSS received salinomycin for 14 d before the first parturition and for approximately 153 d before the second parturition. Daily feed intake was restricted to 2 kg.hd-1.d-1 during gestation and to 3 kg.hd-1.d-1 from weaning to breeding. All sows. had ad libitum access to feed during lactation. Sows were weighed 7 d prior to parturition, at weaning and at breeding. Weaning-to-estrus interval and farrowing interval were recorded for all sows. Litters were weighed at birth and weaning. There were no differences (P greater than .05) between dietary treatments in sow weights before parturition, at weaning or at breeding for either first or second farrowing. The CSS-fed sows lost more weight from weaning to breeding after the first (P less than .03) and second (P less than .05) lactation periods than CS-fed sows. The CSS-fed sows tended to gain more (P = .06) weight during lactation than CS-fed sows. There were no differences (P greater than .05) between treatments in lactation feed intake, weaning-to-estrus interval, farrowing interval, litter size born or weaned, litter weights at birth or at weaning, or in sow culling rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Effects of salinomycin on ruminal characteristics and performance of grazing beef steers.

Grazing trials were conducted for 2 yr using weanling Brahman crossbred beef steers to evaluate graded levels of salinomycin (0, 50, 100 or 150 mg. head-1.d-1) for 161 d and to evaluate salinomycin in a free-choice mineral supplement (99 d). The 40 and 48 steers in trials 1 and 2 had average initial weights of 198 and 285 kg, respectively. In trial 1, steers were group-fed to consume either 0, 50, 100 or 150 mg of salinomycin.head-1.d-1 in .9 kg ground corn while grazing bermudagrass pastures. Both linear (P less than .01) and quadratic (P less than .05) effects were observed for steer performance as salinomycin level increased from 0 to 150 mg.head-1.d-1. Linear increases (P less than .01) in ruminal NH3-N (mg/100 ml) and in the molar proportion of propionate and decreases (P less than .01) in butyrate and acetate/propionate were detected. In trial 2, mineral supplements with and without salinomycin were fed free-choice to steers on bermudagrass pasture. The mean salinomycin intake of 38 mg.head-1.d-1 was lower than anticipated as a result of the instability of salinomycin in the mineral supplement and the slightly lower intake (65 g/d) than anticipated (75 g/d). Performance of steers was not influenced by salinomycin supplementation in trial 2. The ionophore salinomycin at intakes over 50 mg.head-1.d-1 appears to increase the performance of steers grazing bermudagrass pasture.

Animal Feed↗